Navigation Links
CRi's New Vectra(TM) Platform Rapidly Analyzes Tissue Slides and Microarrays in Brightfield and Fluorescence
Date:4/22/2009

DENVER, April 22 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) introduced the Vectra(TM) Intelligent Slide Analysis System at the 100th Annual Meeting of the American Association for Cancer Research (AACR) in Denver. The Vectra system is the world's only multispectral brightfield- and fluorescence-capable solution for rapidly generating high-resolution cellular and tissue images from samples stained with standard H&E, immunohistochemical and immunofluorescence techniques.

The Vectra system utilizes CRi's inForm(TM) Advanced Image Analysis Software, which leverages proprietary machine-learning technology to make it possible to better understand inter-molecular interactions within individual cells.

"Vectra's intelligent scanning approach provides a more efficient and faster alternative to whole-slide scanning," said Clifford Hoyt, VP and CTO at CRi. "You get quantitative information, as well as higher-contrast images of each signal, in many cases impossible

to visualize using any other means."

Compared with conventional means, the new instrument enables much more accurate and dramatically faster imaging of breast cancer and lymphoma tissue, as well as prostate and kidney specimens. Preclinical studies that formerly took weeks or months scanning hundreds or thousands of slides can now be done in days.

According to Dr. Michael Feldman of the University of Pennsylvania, "CRi's Vectra has allowed us to break the boundary of routine immunohistochemical and immunofluorescence studies by supporting multiplexed staining and analysis to reveal the underlying biological processes that are represented in our pathology slides. This has greatly expanded our ability to use pathology slides to ask and answer questions about human disease."

"Vectra and InForm go beyond the capabilities of a routine microscope or whole slide scanner by allowing high-order mutliplexing with advanced cytometric analysis."

Cambridge Research & Instrumentation, Inc (CRi) is a Boston-based biomedical imaging company providing innovative optical imaging solutions for more than 20 years. CRi's multidisciplinary team is dedicated to providing comprehensive solutions that enable our customers to produce breakthroughs in research and medical care, and award-winning products help extract new disease-specific information from biological and clinical samples in the physiological, morphological, and biochemical context of intact tissues and organisms.

For more information visit our website at http://www.cri-inc.com/vectra or contact:

    Ross Nakatsuji
    CRi Marketing/Sales Group Leader
    35-B Cabot Road, Woburn, MA 01801 USA
    (P) 1-781-935-9099, extension 177, (C) 1-781-405-4000,
    (E) rnakatsuji@cri-inc.com


'/>"/>
SOURCE Cambridge Research & Instrumentation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Global Health Leaders Gather to Address Urgent Crisis of Prematurity and Stillbirth
2. The American Federation for Medical Research Unites Top Leaders to Mitigate U.S. Crisis in Clinical Research
3. Resurrection Health Uses Information Technology to Address Critical Care Crisis
4. DDB Worldwide and M/A/R/C Research Find in Time of Economic Crisis: Health Is the New Wealth, Survey Shows Empowering Patients Is Key to Influence
5. In This Economic Crisis Are You Still a Shopaholic? Dr. April Lane Benson Can Help!
6. AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis
7. ZERO Outraged Docs Dont Offer Solution in PSA Crisis
8. Rep. Slaughter Reintroduces Bill to Help Fight Antibiotic Resistance Crisis by Combating Misuse of Antibiotics in Animal Agriculture
9. Hampton Roads Ventures Tackles U.S. Healthcare Crisis Community by Community
10. AIDS Walk New York and Gay Mens Health Crisis Announce Record Corporate Sponsorship Levels
11. In the Midst of a National Nurse Shortage Crisis ... Nurses Celebrate Landmark Legal Settlement That Will Help Ensure Fair Compensation & Bring More RNs to the Bedside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: